| Monday 7 April |
| 09.00 onwards | | Registration
Main Foyer
X |
| 10.30 12.30 | | Bone and Mineral Special Interest Group Satellite: Osteoporosis
In association with the National Osteoporosis Society
Generously supported by Novartis & Roche
Queen's Suite 2
Chairs: J Wass (Oxford) & R Eastell (Sheffield)
O |
| 10.30 | | Reception
|
| | | |
| 11.00 | | Chairman's introduction: osteoporosis - the silent epidemic?
J Wass (Oxford) & R Eastell (Sheffield) |
| | | |
| 11.10 | | NICE ways to manage osteoporosis
P Selby (Manchester) |
| | | |
| 11.30 | | 'But doctor I can't take generic alendronic acid!'
R Eastell (Sheffield) |
| | | |
| 11.50 | | 'But doctor no guidelines apply to my situation'
S Orme (Leeds) |
| | | |
| 12.10 | | So you want to set up an osteoporosis service?
A McLellan (Glasgow) |
| | | |
| 10.30 12.30 | | Andrology Special Interest Group Satellite: Controversies in the diagnosis and management of hypogonadism
Generously supported by Bayer Schering Pharma & ProStrakan
Queen's Suite 1
Chair: H Jones (Sheffield)
O |
| 10.30 | | Hypogonadism and diabetes
H Jones (Sheffield) |
| | | |
| 10.50 | | Aging, frailty and testosterone
F Wu (Manchester) |
| | | |
| 11.10 | | Difficulties in the diagnosis of hypogonadism
S Arver (Stockholm, Sweden) |
| | | |
| 11.30 | | Testosterone and prostate safety
M Feneley (London) |
| | | |
| 11.50 | | Discussion
|
| | | |
| 12.30 13.00 | | Lunch
Hall Q
|
| 13:00 15:00 | | Symposium 1: New twists in appetite/satiety signalling pathways
King's Suite
Chairs: S O'Rahilly (Cambridge) & K Smith (London)
O |
| 13.00 | S9 S9 | Plasma triglycerides and appetite control
W Banks (St Louis, USA) |
| | | |
| 13.30 | S10 S10 | Imaging the brain appetite network
S Luckman (Manchester) |
| | | |
| 14.00 | S11 S11 | Role of central serotonin 2C receptors in appetite control
L Heisler (Cambridge) |
| | | |
| 14.30 | S12 S12 | Central role of AMP-Kinase in appetite control
M Korbonits (London) |
| | | |
| 13:00 15:00 | | Clinical Management Workshop 1: Fibrous dysplasia and McCune-Albright syndrome
Supported by Clinical Endocrinology
Main Auditorium
Chairs: R Thakker (Oxford) & M Cooper (Birmingham)
Wk |
| 13.00 | S44 S44 | The endocrine consequences of McCune-Albright syndrome
P Trainer (Manchester) |
| | | |
| 13.40 | S45 S45 | Molecular genetics and cell biology of McCune-Albright syndrome and fibrous dysplasia
L Weinstein (Bethesda, USA) |
| | | |
| 14.20 | S46 S46 | Medical treatment of fibrous dysplasia of bone
R Chapurlat (Lyon, France) |
| | | |
| 13:00 15:00 | | Molecular Endocrinology Workshop
Queen's Suite 1
Chairs: M Gurnell (Cambridge) & K Boelaert (Birmingham)
O |
| 13.00 | S70 S70 | Cell metabolomics: differential metabolism of glucose and fructose in pancreatic cancer
T Heaney (Los Angeles, USA) |
| | | |
| 14.00 | S71 S71 | Combining mouse genetics, transgenics and knockouts to explore the biology of MC1R aganism and antagonism
I Jackson (Edinburgh) |
| | | |
| 15:00 15:30 | | Coffee
Hall Q
X |
| 15:30 17:30 | | Symposium 2: System-specific effect steroids
King's Suite
Chairs: S Lightman (Bristol) & G Lavery (Birmingham)
O |
| 15.30 | S13 S13 | Glucocorticoid signalling in the brain
S Lightman (Bristol) |
| | | |
| 16.00 | S14 S14 | Glucocorticoids, 11beta HSDs and neuroprotection
M Holmes (Edinburgh) |
| | | |
| 16.30 | S15 S15 | Glucocorticoids, liver, fat and metabolic syndrome
P Stewart (Birmngham) |
| | | |
| 17.00 | S16 S16 | Glucocorticoids, folliculo-stellate cells and the pituitary
H Christian (Oxford) |
| | | |
| 15:30 17:30 | | Oral Communications 1: Young Endocrinologists Prize Session
Main Auditorium
Chairs: J Wass (Oxford) & A McNeilly (Edinburgh)
O |
| 15.30 | OC1 OC1 | Clinical manifestations of familial paraganglioma and phaeochromocytomas in succinate dehydrogenase B gene mutation carriers
|
| | | |
| 15.45 | OC2 OC2 | The ghrelin-cannabinoid axis – a novel pathway in the regulation of appetite and metabolism
|
| | | |
| 16.00 | OC3 OC3 | Does 11beta-HSD1 in visceral adipose tissue (VAT) deliver cortisol to the liver? Studies with portal vein sampling and tracer infusion in humans.
|
| | | |
| 16.15 | OC4 OC4 | Hypoxia and GC signalling regulate macrophage migration inhibitory factor (MIF) gene expression through a common element
|
| | | |
| 16.30 | OC5 OC5 | Placental vascular development and nutrient transport in 11ß-HSD2-/-mice
|
| | | |
| 16.45 | OC6 OC6 | MRAP2 permits the functional expression of the melanocortin-2-receptor: a new member of a new family of melanocortin receptor accessory proteins
|
| | | |
| 17.00 | OC7 OC7 | Testosterone treatment improves muscle strength, lean mass and quality of life in prefrail and frail elderly men: Results from a randomised double-blind placebo-controlled study
|
| | | |
| 17.15 | OC8 OC8 | β-cell 11β-Hydroxysteroid dehydrogenase type 1 contributes to Type 2 Diabetes.
|
| | | |
| 15:30 17:30 | | Oral Communications 2: Reproduction
Queen's Suite 1
Chairs: H Critchley (Edinburgh) & J Prague (London)
O |
| 15.30 | OC9 OC9 | Dynamic responses of oestrogen receptors revealed by fluorescent recovery after photobleaching (FRAP)
|
| | | |
| 15.45 | OC10 OC10 | Expression of somatostatin receptors 1-5 in normal human endometrium through the menstrual cycle
|
| | | |
| 16.00 | OC11 OC11 | Identification of a novel compound heterozygous mutation in the gonadotrophin releasing hormone receptor in two siblings with isolated hypogonadotrophic hypogonadism
|
| | | |
| 16.15 | OC12 OC12 | Modelling Kallmann's Syndrome in the zebrafish
|
| | | |
| 16.30 | OC13 OC13 | Effect of hypoxia and inflammatory and anti-inflammatory signals on gene expression in sheep ovarian surface epithelium (OSE) in vitro.
|
| | | |
| 16.45 | OC14 OC14 | IGF-mediated cell turnover in the human placenta is positively regulated by the protein tyrosine phosphatase, SHP-2.
|
| | | |
| 17.00 | OC15 OC15 | Evaluation of the prevalence of vitamin D deficiency and its treatment in a west London pregnant population
|
| | | |
| 17.15 | OC16 OC16 | Enhanced hypothalamic-pituitary-adrenal axis activation, 5α-reductase activity and insulin resistance distinguishes polycystic ovary syndrome from simple obesity
|
| | | |
| 17:30 17:45 | | Tea
Hall Q
X |
| 17:45 18:45 | | Young Endocrinologist Prize Lectures
Main Auditorium
Chairs: P Stewart (Birmingham) & A McNeilly (Edinburgh)
O |
| 17.45 | S64 S64 | Peptide YY: Food for thought
R Batterham (London) |
| | | |
| 18.15 | S65 S65 | 11b-HSD1 and metabolic disease: a mouses’ Tail
N Morton (Edinburgh) |
| | | |
| 18:45 onwards | | Welcome Reception
Holiday Inn
X |
| 19:45 onwards | | Young endocrinologists quiz night
Generously supported by Fisher Scientific & Novo Nordisk Ltd
Hall D
X |
| Tuesday 8 April |
| 07:15 08:00 | | Clinical Expert 1: Management of prolactinoma
Supported by Clinical Endocrinology
Queen's Suite 1
Chair: R Murray (Leeds)
J Bevan (Aberdeen)
O |
| 07:15 08:00 | | Clinical Expert 2: Clinical management of MEN 1 or 2
Supported by Clinical Endocrinology
Queen's Suite 2
Chair: J Davis (Manchester)
R Thakker (Oxford)
O |
| 08:15 10:15 | | Symposium 3: Hypoxia: its effects on physiology and pathophysiology
Queen's Suite 2
Chairs: M Westwood (Manchester) & K Forbes (Manchester)
O |
| 08.15 | S17 S17 | Hypoxia signalling and VHL
P Maxwell (London) |
| | | |
| 08.45 | S18 S18 | Prenatal hypoxia and early origins of heart disease
D Giussani (Cambridge) |
| | | |
| 09.15 | S19 S19 | Hypoxia, angiogenesis and proliferative diabetic retinopathy
P Bishop (Manchester) |
| | | |
| 09.45 | S20 S20 | Understanding VEGF Action: the role of a novel factor, Dll4
S Wiegand (Regeneron Pharmaceuticals) |
| | | |
| 08:15 10:15 | | Oral Communications 3: Bone, Diabetes and Tumours
Queen's Suite 1
Chairs: R Rosenfeld (Palo Alto, USA) & A Swali (Birmingham)
O |
| 08.15 | OC17 OC17 | Cinacalcet is an effective and well tolerated treatment for MEN1 associated primary hyperparathyroidism
AMEND YOUNG INVESTIGATOR AWARD WINNER
|
| | | |
| 08.30 | OC18 OC18 | Human omental adipose tissue as a key site for the inflammatory 15-lipoxygenase pathway: Implications for metabolic disease.
|
| | | |
| 08.45 | OC19 OC19 | Expression of the parathyroid-specific transcription factor glial cell-Missing B (GCMB) is regulated by GATA3
|
| | | |
| 09.00 | OC20 OC20 | Serum 18 hydroxycortisol identifies aldosteronoma in the differential diagnosis of primary aldosteronism
|
| | | |
| 09.15 | OC21 OC21 | Delineating the mechanisms of visfatin regulation in human AT and the implications of TZD treatment in type 2 diabetes
|
| | | |
| 09.30 | OC22 OC22 | Cataracts are a phenotypic feature of autosomal dominant hypocalcaemia with hypercalciuria (ADHH): lessons from the Nuf mouse model with an activating calcium sensing receptor (CaSR) mutation
|
| | | |
| 09.45 | OC23 OC23 | Obesity resulting from Gs-alpha mutations in the maternal (but not paternal) allele is a consequence of Gs-alpha imprinting in the central nervous system
|
| | | |
| 10.00 | OC24 OC24 | The calcilytic agent NPS2143 rectifies hypocalcaemia in a mouse model, Nuf, that is due to an activating calcium-sensing-receptor (CaSR) mutation: Relevance to Autosomal Dominant Hypocalcaemia with Hypercalciuria
NOVARTIS AWARD WINNER
|
| | | |
| 08:15 10:15 | | Clinical Management Workshop 2 - PCOS: Impact on long term health outcomes
Supported by Clinical Endocrinology
Main Auditorium
Chairs: J Ahlquist (Southend) & T Sathyapal (Hull)
O |
| 08.15 | S47 S47 | Fat metabolism, obesity, NASH in PCOS and insulin resistant states
S Atkin (Hull) |
| | | |
| 08.55 | S48 S48 | Cardiovascular implications of PCOS
F Orio (Naples, Italy) |
| | | |
| 09.35 | S49 S49 | Long-term implications of PCOS in children and adolescents
K Ong (Cambridge) |
| | | |
| 10:15 10:40 | | Coffee
Hall Q
X |
| 10:40 11:25 | | Society for Endocrinology Dale Medal Lecture
Main Auditorium
Chair: J Wass (Oxford)
O |
| S1 S1 | Hormones and ovaries: a lifelong journey
A McNeilly (Edinburgh) |
| | | |
| 11:25 11:55 | | Society for Endocrinology Transatlantic Medal Lecture
Main Auditorium
Chair: J Wass (Oxford)
O |
| S2 S2 | Insulin-like growth factors and the evolution of human growth
R Rosenfeld (Palo Alto, USA) |
| | | |
| 12:00 13:30 | | Lunch
Hall Q
X |
| 12:15 13.00 | | Attended posters
Hall Q
X |
| 13:30 15:30 | | Symposium 4: Thyroid hormones in development: physiology and clinical implications
Main Auditorium
Chairs: S Cheng (Bethesda, USA) & D Bassett (London)
O |
| 13.30 | S21 S21 | Thyroid Hormone Transport and Neurological Development
T Visser (Rotterdam, The Netherlands) |
| | | |
| 14.00 | S22 S22 | New roles of deiodinases in development
A Bianco (Boston, USA) |
| | | |
| 14.30 | S23 S23 | The HPT axis in control of skeletal development
G Williams (London) |
| | | |
| 15.00 | S24 S24 | Clinical implications of fetal and neonatal thyroid development
R Hume (Dundee) |
| | | |
| 13:30 15:30 | | Oral Communications 4: Pituitary and steriods
Queen's Suite 1
Chairs: J Connell (Glasgow) & O Evuarherhe (Bristol)
O |
| 13.30 | OC25 OC25 | Identification of MC2R receptor accessory protein domains required for interaction with MC2R and formation of a functional ACTH responsive receptor
|
| | | |
| 13.45 | OC26 OC26 | A role for CD38 in anterior pituitary somatotrophs? Studies in CD38 null mice
|
| | | |
| 14.00 | OC27 OC27 | Adipose GR knockdown protects against obesity in female mice
|
| | | |
| 14.15 | OC28 OC28 | Pre-receptor cortisol metabolism is a critical regulator of insulin signalling in human adipose tissue
|
| | | |
| 14.30 | OC29 OC29 | Targeting Cyp11b1 expression in mice to model sequelae of congenital adrenal hyperplasia
|
| | | |
| 14.45 | OC30 OC30 | Local cortisol generation by human macrophage subsets by 11beta-hydroxysteroid dehydrogenase type 1 enzyme and its role in ocular immune privilege
|
| | | |
| 15.00 | OC31 OC31 | Do polyunsaturated fatty acids stimulate steroidogenesis through expression of liver x receptor?
|
| | | |
| 15.15 | OC32 OC32 | Coupling of GR cellular distribution and function to the cell cycle
|
| | | |
| 13:30 15:30 | | Young Endocrinologist Session: Obtaining funding for Young Endocrinologists
Queen's Suite 2
Chairs: K Jonas (London) & A Munir (Sheffield)
O |
| 13.30 | S66 S66 | Funding for research fellowships
T Skerry (Sheffield) |
| | | |
| 14.00 | S67 S67 | Clinical Research Fellowships: an insider’s account
F Swords (London) |
| | | |
| 14.30 | S68 S68 | Basic science research lectureships: a day in the life of ...
M Westwood (Manchester) |
| | | |
| 15.00 | S69 S69 | The 'been-to-America' degree revisited: is it really still worth it?
R Fowkes (London) |
| | | |
| 15:30 16:00 | | Tea
Hall Q
X |
| 16:00 18:00 | | Clinical Debate: This house believes that males become menopausal
Supported by Clinical Endocrinology
Main Auditorium
Chair: F Wu (Manchester)
O |
| D1 D1 | For
P Bouloux (London) |
| | | |
| D2 D2 | Against
A Andersson (Copenhagen, Denmark) |
| | | |
| 16:00 18:00 | | Oral Communications 5: Thyroid
Queen's Suite 1
Chairs: S Cheng (Bethesda, USA) & P Beck-Peccoz (Milan, Italy)
O |
| 16.00 | OC33 OC33 | Effect of thyroid status on the skeleton in post-menopausal women: the OPUS study
NOVARTIS AWARD WINNER
|
| | | |
| 16.15 | OC34 OC34 | Maternal isodisomy for a novel human FOXE1 gene mutation in syndromic congenital hypothyroidism
|
| | | |
| 16.30 | OC35 OC35 | Circulating endothelial progenitor cells are reduced in subclinical and overt hypothyroidism
|
| | | |
| 16.45 | OC36 OC36 | Increased skeletal mineralisation in mice lacking type 2 iodothyronine deiodinase
|
| | | |
| 17.00 | OC37 OC37 | Endocytosis involves a CLC-5 and KIF3B Interaction: relevance to thyroid and renal tubular function.
|
| | | |
| 17.15 | OC38 OC38 | Serious vascular events for patients on long-term thyroxine: the TEARS Study
|
| | | |
| 17.30 | OC39 OC39 | HIF-1α is a common downstream target of PI3K and MAPK/ERK signalling in thyroid carcinomas
|
| | | |
| 17.45 | OC40 OC40 | Direct actions of T3 in proliferating chondrocytes regulate endochondral ossification and linear growth
BRITISH THYROID ASSOCIATION AWARD WINNER
|
| | | |
| 16:00 18:00 | | Symposium 5: Androgen receptors – physiology and disease
Queen's Suite 2
Chairs: I McEwan (Aberdeen) & V Bombail (Edinburgh)
O |
| 16.00 | S25 S25 | Tissue-specific androgen receptor knockout models: novel tools in the study of androgen action
G Verhoeven (Leuven, Belgium) |
| | | |
| 16.40 | S26 S26 | Loss of androgen receptor bindingto selective androgen response elements causes a reproductive phenotype in transgenic SPARKI mice
F Claessens (Leuven, Belgium) |
| | | |
| 17.20 | S27 S27 | Androgen receptors in development: biochemical and clinical correlates
I Hughes (Cambridge) |
| | | |
| 16:00 17:00 | | Clinical Expert 1 (repeat): Management of prolactinoma
Supported by Clinical Endocrinology
King's Suite
Chair: R Murray (Leeds)
J Bevan (Aberdeen)
|
| 17:00 18:00 | | Clinical Expert 2 (repeat): Clinical management of MEN 1 or 2
Supported by Clinical Endocrinology
King's Suite
Chair: J Davis (Manchester)
R Thakker (Oxford)
O |
| 19:30 onwards | | Society for Endocrinology banquet
Old Swan Hotel
X |
| Wednesday 9 April |
| 07:15 08:00 | | Clinical Expert 3: Peri-operative care of phaeos
Supported by Clinical Endocrinology
Queen's Suite 1
Chair: M Serpell (Glasgow)
M Serpell (Glasgow)
O |
| 07:15 08:00 | | Clinical Expert 4: Thyroid disease in pregnancy
Supported by Clinical Endocrinology
Queen's Suite 2
Chair: G Brabant (Manchester)
J Lazarus (Cardiff)
O |
| 08:10 08:55 | | Society for Endocrinology Annual General Meeting
Main Auditorium
O |
| 09:00 11:00 | | Symposium 6: The endocrinology of critical illness
Main Auditorium
Chairs: P Stewart (Birmingham) & S Ball (Newcastle-upon-Tyne)
O |
| 09.00 | S28 S28 | Critical illness: an overview of the physiological and metabolic changes
S Baudouin (Newcastle-upon-Tyne) |
| | | |
| 09.30 | S29 S29 | The glucocorticoid axis in critical illness: cause or effect?
M Cooper (Birmingham) |
| | | |
| 10.00 | S30 S30 | Thyroid hormone axis in critical illness
S Ball (Newcastle-upon-Tyne) |
| | | |
| 10.30 | S31 S31 | Insulin and blood glucose changes in critical illness
G Van den Berghe (Leuven, Belgium) |
| | | |
| 09:00 11:00 | | Symposium 7: Evolving endocrine targets for C-type natriuretic peptide (CNP)
Queen's Suite 2
Chairs: C McArdle (Bristol) & K Jonas (London)
O |
| 09.00 | S32 S32 | Emerging Roles for CNP
E Espiner (Christchurch, New Zealand) |
| | | |
| 09.30 | S33 S33 | The new biology of pituitary natriuretic peptides: novel signalling from guanylyl cyclase-B (GC-B) receptors
R Fowkes (London) |
| | | |
| 10.00 | S34 S34 | New aspects of CNP function
R Middendorff (Giessen, Germany) |
| | | |
| 10.30 | S35 S35 | Noval cardiovascular roles for CNP
C Villar (London) |
| | | |
| 09:00 11:00 | | Nurse session 1: Cushing's Syndrome
Queen's Suite 1
Chairs: A Marland (Oxford) & J MacDonald (Oxford)
O |
| 09.00 | S57 S57 | Overview and diagnosis
J Bevan (Aberdeen) |
| | | |
| 09.30 | S58 S58 | Cushing's: the worst case scenario
V Thornton-jones (Oxford) |
| | | |
| 10.00 | S59 S59 | A case of cyclical Cushing's Syndrome?
V Kieffer (Leicester) |
| | | |
| 10.30 | S60 S60 | Cushing's Syndrome - a success story?
S Cox (Torquay) |
| | | |
| 11:00 11:30 | | Coffee
Hall Q
X |
| 11:30 12:05 | | Society for Endocrinology European Medal Lecture
Main Auditorium
Chair: J Buckingham (London)
O |
| S3 S3 | Testicular dysgenesis syndrome (TDS): clinical and environmental aspects
N Skakkebaek (Copenhagen, Denmark) |
| | | |
| 12:05 12:40 | | Society for Endocrinology Asia and Oceania Medal Lecture
Main Auditorium
Chair: J Wass (Oxford)
O |
| S4 S4 | Unraveling the metabolic mysteries regulating body composition: new insights into old hormones
K Ho (Sydney, Australia) |
| | | |
| 12:40 14:15 | | Lunch
Hall Q
X |
| 13.00 13.45 | | Attended posters
Hall Q
|
| 14:15 16:15 | | Symposium 8: Inflammation and the adipocyte – integrated pathways that regulate disease risk
Queen's Suite 2
Chairs: K Chapman (Edinburgh) & N Fernandes da Silva (Warwick)
O |
| 14.15 | S36 S36 | Leptin as a proinflammatory cytokine
G Lord (London) |
| | | |
| 14.45 | S37 S37 | Nuclear receptors and regulation of inflammatory pathways
B Staels (Lille, France) |
| | | |
| 15.15 | S38 S38 | Anti-inflammatory and pro-resolution lipid mediators: lessons for obesity-related inflammation.
D Gilroy (London) |
| | | |
| 15.45 | S39 S39 | Adipose tissue and chronic inflammation
S Kumar (Warwick) |
| | | |
| 14:15 16:15 | | Clinical Mangement Workshop 3: Managing the obese patient
Supported by Clinical Endocrinology
Main Auditorium
Chairs: R Murray (Leeds) & S Aylwin (London)
O |
| 14.15 | S50 S50 | Managing the obese patient: lifestyle intervention and prescriptive exercise
R Andrews (Bristol) |
| | | |
| 14.45 | S51 S51 | Obesity management – the role of drugs in the 21st Century
J Wilding (Liverpool) |
| | | |
| 15.15 | S52 S52 | New insulins - suck 'em and see!
A Robinson (Bolton) |
| | | |
| 15.45 | S53 S53 | Role of bariatric surgery
S Aylwin (London) |
| | | |
| 14:15 16:15 | | Nurse session 2: Diabetes insipidus
Queen's Suite 1
Chairs: V Kieffer (Leicester) & V Thornton-Jones (Oxford)
O |
| 14.15 | S61 S61 | Overview and how to do a water deprivation test: interpretation of results
J Wass (Oxford) |
| | | |
| 14.55 | S62 S62 | Water deprivation test: a ‘real’ case
M O' Connor (Oxford) |
| | | |
| 15.35 | S63 S63 | Water deprivation test: a 'red herring' case
J MacDonald (Oxford) |
| | | |
| 16:15 16:45 | | Tea
Hall Q
X |
| 16:15 16:45 | | Nurses Tea
Generously supported by Ipsen Ltd
Conference Suite
|
| 16:45 17:05 | | Awards ceremony
Main Auditorium
Chair: J Wass (Oxford)
O |
| 17:05 17:40 | | British Thyroid Association Pitt-Rivers Lecture
Supported by the Clinical Endocrinology Trust
Main Auditorium
Chair: A Weetman (Sheffield)
O |
| S5 S5 | Thyroid hormone receptors, mutations, and cancer development
S Cheng (Bethesda, USA) |
| | | |
| 17:40 18:15 | | Clinical Endocrinology Visiting Professor Lecture
Supported by the Clinical Endocrinology Trust
Main Auditorium
Chair: A Weetman (Sheffield)
O |
| S6 S6 | Inappropriate secretion of TSH
P Beck-Peccoz (Milan, Italy) |
| | | |
| 18:15 18:45 | | PCOS satellite reception
A buffet will be sereved for those attending the satellite
Generously supported by Almirall Ltd
Upper foyer
|
| 18:15 18:45 | | Neuroendocrine Tumours Satellite reception
A buffet will be available for those attending the satellite
Generously supported by Novartis
Queen's Suite foyer
|
| 18:45 20:45 | | PCOS and Metabolic Syndrome Special Interest Group Satellite: Advances in PCOS in the last 12 months
Generously supported by Almirall Ltd
Main Auditorium
Chairs: S Atkin (Hull) & H Randeva (Warwick)
O |
| 18.45 | | An update and highlights of the basic science advances of PCOS
H Randeva (Warwick) |
| | | |
| 19.15 | | An update and highlights of the reproductive aspects of PCOS
A Balen (Leeds) |
| | | |
| 19.45 | | An update and highlights of the cosmetic aspects of PCOS
A Layton (Harrogate) |
| | | |
| 20.15 | | Discussion
|
| | | |
| 18:45 20:45 | | Neuroendocrine Tumours Satellite
Generously supported by Novartis
Queen's Suite 1
Chairs: D O'Shea (Dublin, Ireland) & K Meeran (London)
O |
| 18.45 | | Clinical case discussions and current clinical trials for neuroendocrine tumours
K Meeran (London) & J Newell-Price (Sheffield) |
| | | |
| 19.15 | | Diagnostic and treatment algorithm for neuroendocrine tumours
D O'Shea (Dublin, Ireland) |
| | | |
| 19.45 | | Mechanisms underlying neuroendocrine tumourigenesis and development of models
R Thakker (Oxford) |
| | | |
| 20.15 | | Tumour targetted radioactive treatment of neuroendocrine tumours
D Kwekkeboom (Rotterdam, The Netherlands) |
| | | |
| Thursday 10 April |
| 07:15 08:00 | | Clinical Expert 5: Obesity surgery - who, what and when?
Supported by Clinical Endocrinology
Queen's Suite 1
Chair: R Malik (Manchester)
J Wilding (Liverpool)
O |
| 07:15 08:00 | | Clinical Expert 6: Cushing's Syndrome in pregnancy
Supported by Clinical Endocrinology
Queen's Suite 2
Chair: P Trainer (Manchester)
A James (Newcastle-upon-Tyne)
O |
| 08:15 08:50 | | Society for Endocrinology Medal Lecture
Main Auditorium
Chair: D Ray (Manchester)
O |
| S7 S7 | The endocrinology of menstruation
H Critchley (Edinburgh) |
| | | |
| 08:55 09:30 | | Clinical Endocrinology Trust Lecture
Supported by the Clinical Endocrinology Trust
Main Auditorium
Chair: L Rees (London)
O |
| S8 S8 | Aldosterone and cardiovascular function: a lifetime of damage
J Connell (Glasgow) |
| | | |
| 09:30 10:00 | | Coffee
Hall Q
X |
| 10:00 12:00 | | Symposium 9: Recent advances and new treatment options in diabetes
Main Auditorium
Chairs: A Harte (Warwick) & R Davies (Manchester)
O |
| 10.00 | S40 S40 | New approaches to treating diabetic microvascular complications
R Malik (Manchester) |
| | | |
| 10.30 | S41 S41 | Incretin-based therapies
C Bailey (Birmingham) |
| | | |
| 11.00 | S42 S42 | Immune therapy: prevention is better than cure
B Roep (Leiden, The Netherlands) |
| | | |
| 11.30 | S43 S43 | Islet transplantation - way to go!
J Shaw (Newcastle-upon-Tyne) |
| | | |
| 10:00 12:00 | | Clinical Management Workshop 4: Transitional endocrinology
Supported by Clinical Endocrinology
Queen's Suite 1
Chair: J Davis (Manchester)
O |
| 10.00 | S54 S54 | The management of Prader-Willi syndrome from paediatric to adult care
A Lindgren (Stockholm, Sweden) |
| | | |
| 10.40 | S55 S55 | The management of congenital adrenal hyperplasia from paediatric to adult care
P Clayton (Manchester) |
| | | |
| 11.20 | S56 S56 | The management of Turner Syndrome from paediatric to adult care
G Conway (London) |
| | | |
| 12:00 12:45 | | Clinical Expert 3 (repeat): Peri-operative care of phaeos
Supported by Clinical Endocrinology
Queen's Suite 1
Chair: M Serpell (Glasgow)
M Serpell (Glasgow)
O |
| 12:00 12:45 | | Clinical Expert 4 (repeat): Thyroid disease in pregnancy
Supported by Clinical Endocrinology
Queen's Suite 2
Chair: G Brabant (Manchester)
J Lazarus (Cardiff)
O |
| 12:45 13:30 | | Clinical Expert 5 (repeat): Obesity surgery - who, what and when?
Supported by Clinical Endocrinology
Queen's Suite 1
Chair: R Malik (Manchester)
J Wilding (Liverpool)
O |
| 12:45 13:30 | | Clinical Expert 6 (repeat): Cushing's Syndrome in pregnancy
Supported by Clinical Endocrinology
Queen's Suite 2
Chair: P Trainer (Manchester)
A James (Newcastle-upon-Tyne)
O |